Clinical Trials Directory

Trials / Completed

CompletedNCT00666445

Improved Diagnosis of Alzheimer's Disease Using the Synchronous Neural Interaction™ Test

Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG) and the Synchronous Neural Interaction™ Test: AD Template Development Study

Status
Completed
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Orasi Medical, Inc. · Industry
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

This study is designed to test the hypothesis that the Synchronous Neural Interaction™ Test is useful for diagnosing Probable Alzheimer's Disease according to standard criteria. Subjects diagnosed with Alzheimer's Disease as well as age-matched normal control subjects will be evaluated for symptoms of Alzheimer's Disease and those meeting inclusion criteria will undergo a brief, non-invasive scan of brain function using a magnetoencephalography (MEG). The scan itself lasts 1 minute while the subject is asked to stare at a dot projected in front of them on a video screen. Orasi Medical believes that patterns of brain activity measured at rest are indicative of Alzheimer's Disease pathology. The protocol is amended to add a follow-up assessment for previously enrolled and completed subjects who agree to participate in the follow-up assessment approximately 9 - 15 months after initial study enrollment. Subjects who agree to participate in the follow-up assessment will undergo the same standardized tests and MEG scan procedure as completed in the initial study.

Conditions

Timeline

Start date
2008-04-01
Primary completion
2009-12-01
Completion
2009-12-01
First posted
2008-04-25
Last updated
2010-08-13

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00666445. Inclusion in this directory is not an endorsement.

Improved Diagnosis of Alzheimer's Disease Using the Synchronous Neural Interaction™ Test (NCT00666445) · Clinical Trials Directory